Nocturnal melatonin plasma levels in patients with OSAS: The effect of CPAP

European Respiratory Journal

Volumn 30, Issue 3, 2007, Pages 496-500

  Hernandez C ^a   Abreu, J ^a   Abreu, P ^b   Castro, A ^a   Jimenez A ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Continuous positive airway pressure titration; Melatonin secretion; Obstructive sleep apnoea syndrome

Indexed keywords

MELATONIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NIGHT; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; BLOOD; CIRCADIAN RHYTHM; MIDDLE AGED; PHYSIOLOGY; SLEEP STAGE;

ADULT; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES;

EID: 38449085293     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00051906     Document Type: Article

References (25)

1. Wetterberg L. Melatonin in humans. Physiological and clinical studies. J Neural Transm Suppl 1978; 13: 289-330.
2. Ganguly S, Coon SL, Klein DC. Control of melatonin synthesis in the mammalian pineal gland: the critical role of serotonin acetylation. Cell Tissue Res 2002; 309: 127-137.
3. Lewy AJ, Wehr TA, Goodwin RK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980; 210: 1267-1269.
4. Anton-Tay F, Diaz JL, Fernánez-Guardiola G. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sci I 1971; 10: 841-850.
5. Kräuchi K, Cajochen C, Möri D, Graw P, Wirz-Justice A. Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature. Am J Physiol 1997; 272: R1178-R1188.
6. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000; 526: 695-702.
7. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulphate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985; 60: 1166-1173.
8. Kräuchi K, Cajochen C, Pache M, Flammer J, Wirz-Justice A. Thermoregulatory effects of melatonin in relation to sleepiness. Chronobiol Int 2006; 23: 475-484.
9. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005; 25: 514-520.
10. Marti S, Sampol G, Muñoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-1518.
11. Lacasse Y, Godbout C, Sériès F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J 2002; 19: 499-503.
12. Wikner J, Svanborg E, Wetterberg L, Röjdmark S. Melatonin secretion and excretion in patients with obstructive sleep apnoea syndrome. Sleep 1997; 20: 1002-1007.
13. Ulfberg J, Micic S, Strom J. Afternoon serum-melatonin in sleep disordered breathing. J Intern Med 1998; 244: 163-168.
14. Brzecka A, Piesiak P, Zareba-Bogdał E, Zierkiewicz G, Plamieniak Z. Rhythm of melatonin excretion in obstructive sleep apnoea syndrome. Pneumonol Alergol Pol 2001; 69: 650-654.
15. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
16. Elmasry A, Lindberg E, Hedner J, Janson C, Boman G. Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Respir J 2002; 19: 511-517.
17. Heitmann J, Ehlenz K, Penzel T, et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23: 255-262.
18. Montserrat JM, Amilibia J, Barbé F, et al. Tratamiento del síndrome de apneas-hipopneas durante el sueño. [Treatment of sleep apnea-hypoapnea syndrome]. Arch Bronconeumol 1998; 34: 204-206.
19. Rechtschaffen A, Kales AA, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. NIH Publication No. 204. Washington, Government Printing Office, 1968.
20. Manz B, Seidel A, Alexander H, et al. Development and validation of a radioimmunoassay for serum melatonin. J Clin Chem Clin Biochem 1989; 27: 797-802.
21. Wetterberg L, ed. Light and Biological Rhythms in Man. Oxford, Pergamon Press, 1993.
22. Sukegawa M, Noda A, Sugiura T, et al. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 2005; 28: 519-522.
23. Bratel T, Wennlund A, Carlström K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999; 93: 1-7.
24. Burgess HJ, Sletten T, Savic N, Gilbert SS, Dawson D. Effects of bright light and melatonin on sleep propensity, temperature, and cardiac activity at night. J Appl Physiol 2001; 91: 1214-1222.
25. Drake CL, Day R, Hudgel D, et al. Sleep during titration predicts continuous positive airway pressure compliance. Sleep 2003; 26: 308-311.